Kamada Ltd.(TEL Aviv Stock Exchange : KMDA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||0.53%||572.36||2.7%||$454.63m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.33%||6.09||0.7%||$425.71m|
|GILD||Gilead Sciences, Inc.||0.37%||67.24||1.0%||$393.07m|
|XLRN||Acceleron Pharma, Inc.||0.12%||173.95||5.3%||$346.86m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.91%||183.52||1.9%||$275.34m|
|XENE||Xenon Pharmaceuticals, Inc.||0.75%||30.86||0.4%||$166.06m|
|CRSP||CRISPR Therapeutics AG||-1.55%||95.56||0.6%||$159.15m|
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.